Concord Drugs Ltd Share Price

Q: What is the share price of Concord Drugs Ltd today?

Concord Drugs Ltd share price as on 18 Jul 2026 is ₹78.0

Pharmaceuticals

BSE: 538965 Small Cap ISIN: INE858L01010

As on 18 July 2026 at 21:50 IST

₹78

-0.54

(-0.69%)

Sell Buy

Over 1 Month

-6.70%

Over 6 Months

-3.07%

Over 1 Year

153.44%

Over 3 Years

186.22%

Concord Drugs Ltd Summary

Close ₹78.54

Open ₹83.90

High ₹83.90

Low ₹78.40

Volume 2,554

Net Turnover (in Cr) ₹0.02

52Wk High ₹92.52

52Wk Low ₹29

52Wk High / Low

92.52

Concord Drugs Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹103.48

EPS (TTM) 0.79

Book Value (BV) 36.82

Div. Yield -

P/E (TTM) 99.42

Price/Book Value 2.13

Delivery % 97.49 %

Face Value 10

Key Ratios

PE Ratio 103.60

PB Ratio 0.91

EV to Sales 1.29

PEG Ratio -3.63

ROA 0.56

ROE 0.88

Debt-Equity 0.47

Net Profit Margin 0.81

Operating Profit Margin 10.24

Concord Drugs Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	45.26	44.93	52.09	59.06
Total Expenses	44.57	44.30	50.84	56.81
Profit Before Tax	0.69	0.63	1.25	2.25
Profit After Tax	0.34	0.47	0.99	1.59
Operating Profit After Depreciation	2.72	2.50	2.96	3.93

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Fixed Assets	11.57	11.04	12.28	13.33
Total Non Current Assets	24.38	21.29	14.77	14.55
Total Current Assets	40.76	37.52	43.46	41.89
Total Assets	65.14	58.81	58.23	56.45
Total Shareholder's Fund	34.11	33.82	31.70	28.36

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash From Operating Activities	3.72	0.79	1.66	0.77
Net Cash Used In Investing Activities	-2.32	-1.01	-2.27	-2.44
Net Cash Used In Financing Activities	-1.43	0.28	0.62	1.68

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	36.95	43.27	51.32	59.06	51.45
Total Expenses	36.31	42.71	50.20	56.81	50.92
Profit Before Tax	0.64	0.56	1.13	2.25	4.29
Profit After Tax	0.30	0.42	0.89	1.59	3.28
Operating Profit After Depreciation	2.36	2.15	2.75	3.93	1.95

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	11.54	10.99	12.22	13.33	13.19
Total Non Current Assets	25.16	22.01	15.23	14.55	13.86
Total Current Assets	33.42	34.28	41.40	41.89	36.03
Total Assets	58.58	56.30	56.63	56.45	49.88
Total Shareholder's Fund	34.11	33.82	31.70	28.36	26.77

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	3.16	1.96	2.24	0.77	1.62
Net Cash Used In Investing Activities	-2.32	-1.21	-2.27	-2.44	-3.67
Net Cash Used In Financing Activities	-0.87	-0.69	0.05	1.68	2.07

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	37.90	16.99	10.28	13.61	10.40
Total Expenses	36.41	16.04	9.18	12.59	9.35
Profit Before Tax	0.74	0.30	0.27	0.16	0.06
Profit After Tax	0.53	0.22	0.19	0.12	0.04
Operating Profit after Depreciation	1.49	0.95	1.10	1.02	1.05

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	35.55	16.84	10.07	13.38	7.96
Total Expenses	34.13	15.97	9.07	12.44	7.04
Profit Before Tax	0.74	0.29	0.26	0.15	0.02
Profit After Tax	0.52	0.22	0.19	0.11	0.01
Operating Profit after Depreciation	1.43	0.89	1	0.94	0.92

Concord Drugs Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 76.66

S2 74.78

S3 71.16

Pivot 80.28

R1 82.16

R2 85.78

R3 87.66

Moving Average

20 SMA 80.52

50 SMA 80.16

100 SMA 78.70

200 SMA 75.81

Concord Drugs Ltd Corporate Actions

No available data

Concord Drugs Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Concord Drugs Ltd Top Mutal Funds Invested

No data available

Concord Drugs Ltd News

Concord Drugs to hold board meeting

On 27 May 2026

19 May 2026, 01:59 pm

Concord Drugs to declare Quarterly Results

On 14 February 2026

03 Feb 2026, 12:54 pm

Concord Drugs gains on securing Rs 15-cr order

Concord Drugs rose 3.48% to Rs 86 after the company announced that it has secured an order worth Rs 14.71 crore for the supply of various pharmaceutical products.

30 Dec 2025, 12:56 pm

Concord Drugs to announce Quarterly Result

On 13 November 2025

05 Nov 2025, 02:13 pm

Concord Drugs to conduct AGM

On 30 September 2025

16 Sep 2025, 03:34 pm

Concord Drugs Ltd Stock Analysis

Annual revenue for Concord Drugs Ltd decreased by 14.61% to ₹36.95 crore in FY 2025 from ₹43.27 crore in FY 2024.
Annual Net Profit for Concord Drugs Ltd decreased by 29.49% to ₹0.30 crore in FY 2025 from ₹0.42 crore in FY 2024.
Promoter Shareholding in Concord Drugs Ltd remains unchanged by 0.00% in the most recent quarter, from 54.39% in December 2025 to 54.39% in March 2026.
Concord Drugs Ltd delivered a 1-year return of 153.44% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Concord Drugs Ltd share price moved down by 0.69% from its previous close of INR ₹78.54. The latest Concord Drugs Ltd share price is INR ₹78.
Concord Drugs Ltd share price today has been at a low of 74.70 and a high of 78.49. Over the past 52 weeks, the Concord Drugs Ltd share price has seen a low of 29 and a high of 92.52.